EOFLOW Co., Ltd. (KOSDAQ:294090)

South Korea · Delayed Price · Currency is KRW

1,490.00

-89.00 (-5.64%)

At close: Mar 21, 2025

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Drug Delivery Systems	5.03B	6.59B	6.71B	693.27M	21.65M
Drug Delivery Systems Growth	-23.65%	-1.77%	867.57%	3101.49%	-
Total	5.03B	6.59B	6.71B	693.27M	21.65M
Total Growth	-23.65%	-1.77%	867.57%	3101.49%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Korean Business Division	5.45B	5.86B	6.66B	693.27M	21.65M
Korean Business Division Growth	-6.95%	-11.95%	860.25%	3101.49%	-
Inter-Departmental Elimination, Etc.	-1.24B	-4.90B	-2.79B	-295.01M	-
US Business Division	818.85M	5.63B	2.84B	295.01M	-
US Business Division Growth	-85.46%	98.36%	862.55%	-	-
Total	5.03B	6.59B	6.71B	693.27M	21.65M
Total Growth	-23.65%	-1.77%	867.57%	3101.49%	-

Source: S&P Global Market Intelligence.